Ads
related to: pfizer covid vaccine
Search results
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 3 days agoDuring the March quarter, the U...projection. The company also raised its sales outlook for the...
Novavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine
BenefitsPRO· 4 days agoCOVID-19 and flu shot. Novavax will receive $500 million in upfront payments as well as a further...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 3 days agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
CNBC· 4 days agoA vial labelled "Novavax V COVID-19 Vaccine" is seen in this illustration taken January 16, 2022....
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 3 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance via AOL· 7 days agoNovavax struggled after its COVID-19 vaccine was delayed by manufacturing issues early in...
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 4 days agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel COVID...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Motley Fool via Yahoo Finance· 3 days agoWhy does Sanofi want the Novavax COVID vaccine? The Novavax COVID-19 vaccine, which is called...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 5 days ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
Expert reaction: AstraZeneca withdraws its COVID-19 vaccine
Cosmos· 7 days agoAstraZeneca developed the first vaccine for COVID-19, beating the competition, but this week they’ve...